Literature DB >> 238274

A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis.

M Aylward, J Maddock, R Wheeldon, R J Parker.   

Abstract

In patients with rheumatoid arthritis neither indomethacin nor aspirin influenced the levels of the erythrocyte sedimentation rate (e.s.r) or serum acute-phase proteins fibrinogen, haptoglobin, C-reactive protein and alphaI acid-glycoprotein). Treatment with D-penicillamine, sodium aurothiomalate, or alclofenac produced a significant reduction both in acute-phase protein levels and in e.s.r. Each of the drugs displaced L-tryptophan from plasma proteins in vivo but withdrawal of indomethacin and aspirin was followed immediatley by excessive binding of this amino acid to circulating proteins:this phenomenon was not observed when alclofenac, sodium aurothiomalate or D-penicillamine were withdrawn. It has been demonstrated that disease activity in rheumatoid arthritis is reflected in acute-phase protein concentrations and in the extent to which L-tryptophan is bount to plasma protein. It is suggested that drugs which profoundly affect these parameters provide not only symptomatic relieft but also possible beneficial effects upon the disease process itself.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 238274     DOI: 10.1093/rheumatology/14.2.101

Source DB:  PubMed          Journal:  Rheumatol Rehabil        ISSN: 0300-3396


  10 in total

1.  Inflammatory disease and its control in rheumatic disorders.

Authors:  F D Hart
Journal:  Br Med J       Date:  1975-10-25

2.  Fenclofenac in the treatment of rheumatoid arthritis and ankylosing spondylitis.

Authors:  M S Akyol; M Anderson; M Thompson
Journal:  Proc R Soc Med       Date:  1977

3.  Effect of short-term aspirin use on C-reactive protein.

Authors:  D Feng; R P Tracy; I Lipinska; J Murillo; C McKenna; G H Tofler
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

4.  Alclofenac: a review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

Review 5.  The pharmacological consequences of the binding of anti-rheumatic drugs to plasma proteins in the treatment of rheumatoid arthritis.

Authors:  J N McArthur
Journal:  Agents Actions       Date:  1979-06

6.  Letter: Natural oestrogen replacement therapy and blood clotting.

Authors:  M Aylward; J Maddock; P Rees
Journal:  Br Med J       Date:  1976-01-24

7.  New drugs for inflammation - a clinical viewpoint for their assessment.

Authors:  B McConkey
Journal:  Agents Actions       Date:  1976-09

Review 8.  Mechanisms of action of gold.

Authors:  J H Leibfarth; R H Persellin
Journal:  Agents Actions       Date:  1981-11

9.  A new screen for anti-inflammatory agents. Estimation of rat serum acute phase alpha2-macroglobulin levels using an electroimmunoassay.

Authors:  B A Baldo; S C Chow; C Euers
Journal:  Agents Actions       Date:  1981-11

10.  Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.

Authors:  J S Dixon; M E Pickup; J R Lowe; C Hallett; M R Lee; V Wright
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.